UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.295

Sortiert nach

A translational drug-screening tool for interrogating the effect of anti-TGF-β therapy on fibroblast activity and the desmoplastic reaction

Annals of oncology, 2018-10, Vol.29, p.viii10-viii10

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study

Journal of clinical oncology, 1992-03, Vol.10 (3), p.390-397

1992

Link zum Volltext

Verfügbarkeit prüfen

The Danish landscape of providing support for caregivers of people with potentially life-threatening disease: A cross-sectional study among representatives of health services in Danish municipalities and hospitals

Scandinavian journal of public health, 2024-06, Vol.52 (4), p.494-501

2024

Link zum Volltext

Verfügbarkeit prüfen

In vitro circumvention of anthracycline-resistance in ehrlich ascites tumour by anthracycline analogues

Biochemical pharmacology, 1990-06, Vol.39 (11), p.1721-1726

1990

Link zum Volltext

Verfügbarkeit prüfen

Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study

European journal of haematology, 1995-02, Vol.54 (2), p.78-84

1995

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacodynamic studies of subcutaneously administered recombinant human interleukin‐3 following chemotherapy for non‐Hodgkin's lymphoma

British journal of haematology, 1995-10, Vol.91 (2), p.367-373

1995

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF

European journal of clinical investigation, 1992-01, Vol.22 (1), p.45-49

1992

Link zum Volltext

Verfügbarkeit prüfen

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents

Annals of internal medicine, 1985-08, Vol.103 (2), p.195

1985

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin's disease and age

European journal of haematology, 1989-08, Vol.43 (2), p.127-135

1989

Link zum Volltext

Verfügbarkeit prüfen

Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment

Cancer, 1988-04, Vol.61 (8), p.1719-1727

1988

Link zum Volltext

Verfügbarkeit prüfen

Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony-stimulating factor in patients with lymphoma

European journal of clinical investigation, 1991-04, Vol.21 (2), p.219-224

1991

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin's disease stages I and II with infradiaphragmatic presentation: A rare and prognostically unfavourable combination

European journal of haematology, 1988-05, Vol.40 (5), p.396-402

1988

Link zum Volltext

Verfügbarkeit prüfen

Effect of anthracycline analogs on photolabelling of p-glycoprotein by [ I]iodomycin and [ H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells

British journal of cancer, 1993-02, Vol.67 (2), p.226-231

1993

Link zum Volltext

Verfügbarkeit prüfen

Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor

European journal of haematology, 1993-01, Vol.50 (1), p.32-36

1993

Link zum Volltext

Verfügbarkeit prüfen

S-phase induction by interleukin-6 followed by chemotherapy in patients with refractory multiple myeloma

Leukemia research, 1998-11, Vol.22 (11), p.983-989

1998

Link zum Volltext

Verfügbarkeit prüfen

Follicular low-grade non-Hodgkin's lymphoma: Long-term outcome with or without tumor progression

European journal of haematology, 1989-02, Vol.42 (2), p.155-163

1989

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in Hodgkin's disease stage IV

European journal of haematology, 1988-10, Vol.41 (4), p.359-367

1988

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab

Scientific reports, 2021-01, Vol.11 (1), p.865-865, Article 865

2021

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human interleukin‐3: pharmacokinetics after intravenous and subcutaneous bolus injection and effects on granulocyte kinetics

British journal of haematology, 1994-08, Vol.87 (4), p.700-707

1994

Link zum Volltext

Verfügbarkeit prüfen

Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer

BMC cancer, 2023-10, Vol.23 (1), p.949-949, Article 949

2023

Link zum Volltext

Verfügbarkeit prüfen

Controversies in the management of Hodgkin's disease

European journal of cancer & clinical oncology, 1991, Vol.27 (3), p.306-309

1991

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden

European journal of haematology, 1988-07, Vol.41 (1), p.80-87

1988

Link zum Volltext

Verfügbarkeit prüfen

Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease

The European respiratory journal, 1990-11, Vol.3 (10), p.1140-1145

1990

Link zum Volltext

Verfügbarkeit prüfen

Jejunogastric Intussusception: A Rare Complication of Gastric Surgery

Case reports in surgery, 2013-01, Vol.2013, p.838360-3

2013

Link zum Volltext

Verfügbarkeit prüfen

Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B

Journal of clinical oncology, 1986-06, Vol.4 (6), p.838-846

1986

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.065)
Mit Volltextzugriff
(964)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Ugeskrift For Læger
(52)
Acta Medica Scandinavica
(50)
Journal Of The American College Of Cardiology
(43)
Gastroenterology
(30)
Journal Of Clinical Oncology
(25)
Cancer
(24)
Acta Ophthalmologica
(18)
European Journal Of Haematology
(18)
Scandinavian Journal Of Haematology
(18)
Hpb
(17)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A translational drug-screening tool for interrogating the effect of anti-TGF-β therapy on fibroblast activity and the desmoplastic reaction

Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study

The Danish landscape of providing support for caregivers of people with potentially life-threatening disease: A cross-sectional study among representatives of health services in Danish municipalities and hospitals

In vitro circumvention of anthracycline-resistance in ehrlich ascites tumour by anthracycline analogues

Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study

Pharmacokinetic and pharmacodynamic studies of subcutaneously administered recombinant human interleukin‐3 following chemotherapy for non‐Hodgkin's lymphoma

Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents

Hodgkin's disease and age

Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment

Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony-stimulating factor in patients with lymphoma

Hodgkin's disease stages I and II with infradiaphragmatic presentation: A rare and prognostically unfavourable combination

Effect of anthracycline analogs on photolabelling of p-glycoprotein by [ I]iodomycin and [ H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells

Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor

S-phase induction by interleukin-6 followed by chemotherapy in patients with refractory multiple myeloma

Follicular low-grade non-Hodgkin's lymphoma: Long-term outcome with or without tumor progression

Prognostic factors in Hodgkin's disease stage IV

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab

Recombinant human interleukin‐3: pharmacokinetics after intravenous and subcutaneous bolus injection and effects on granulocyte kinetics

Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer

Controversies in the management of Hodgkin's disease

Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden

Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease

Jejunogastric Intussusception: A Rare Complication of Gastric Surgery

Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B

Suchergebnisse filtern